MUMBAI, India, Nov. 7 -- Intellectual Property India has published a patent application (202527071576 A) filed by Shanghai Henlius Biotech Inc.; Shanghai Henlius Biopharmaceutical Co. Ltd.; and Shanghai Henlius Biologics Co. Ltd., Shanghai, on July 28, for 'anti pdl1 antibodies multispecific antibodies and methods of use.'
Inventor(s) include Baral Toya; Chang Jen Kuan; Muda Marco; Xu Wenfeng; Jiang Wei Dong; Xue Jie; Lin Pei Hua; and Issafras Hassan.
The application for the patent was published on Nov. 7, under issue no. 45/2025.
According to the abstract released by the Intellectual Property India: "Provided is a multispecific antibody that binds to PDL1 and CD47 useful for treating or preventing cancer. The multispecific antibody comp...